Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000194182 | SCV000247654 | likely benign | not specified | 2019-05-23 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000194182 | SCV000304670 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000960925 | SCV001107954 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001103552 | SCV001260325 | uncertain significance | Hyperinsulinemic hypoglycemia, familial, 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001105472 | SCV001262440 | benign | Diabetes mellitus, transient neonatal, 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001105473 | SCV001262441 | benign | Maturity-onset diabetes of the young type 13 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Gene |
RCV000960925 | SCV001790225 | likely benign | not provided | 2020-11-17 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26740944) |
Athena Diagnostics | RCV000194182 | SCV001880049 | benign | not specified | 2020-09-30 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002227089 | SCV002505935 | uncertain significance | Hyperinsulinemia | criteria provided, single submitter | research | Mutations in KCNJ11 gene can generally cause decreased production and secretion of insulin. This can lead to MODY. However, the role of this particular variant (rs116392938) of KCNJ11 gene in congenital hyperinsulinism and MODY remains uncertain. | |
ARUP Laboratories, |
RCV000960925 | SCV003799950 | likely benign | not provided | 2022-09-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003165435 | SCV003904823 | likely benign | Inborn genetic diseases | 2023-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000960925 | SCV004136021 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | KCNJ11: BP4, BP7 |
Diagnostic Laboratory, |
RCV000960925 | SCV002034903 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000960925 | SCV002036849 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001833136 | SCV002085115 | likely benign | Permanent neonatal diabetes mellitus | 2019-10-22 | no assertion criteria provided | clinical testing |